These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 3563964
1. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats. Diness V, Ostergaard PB. Thromb Haemost; 1986 Dec 15; 56(3):318-22. PubMed ID: 3563964 [Abstract] [Full Text] [Related]
2. A comparison of the antithrombotic and haemorrhagic effects of a low molecular weight heparin (LHN-1) and conventional heparin. Diness V, Nielsen JI, Pedersen PC, Wolffbrandt KH, Ostergaard PB. Thromb Haemost; 1986 Jun 30; 55(3):410-4. PubMed ID: 3750271 [Abstract] [Full Text] [Related]
3. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA. Thromb Haemost; 1995 Mar 30; 73(3):439-43. PubMed ID: 7667826 [Abstract] [Full Text] [Related]
4. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice. Bernat A, Hoffmann P, Herbert JM. Thromb Haemost; 1996 Nov 30; 76(5):715-9. PubMed ID: 8950779 [Abstract] [Full Text] [Related]
5. Neutralization of enoxaparine-induced bleeding by protamine sulfate. Van Ryn-McKenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR. Thromb Haemost; 1990 Apr 12; 63(2):271-4. PubMed ID: 2163553 [Abstract] [Full Text] [Related]
6. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Massonnet-Castel S, Pelissier E, Bara L, Terrier E, Abry B, Guibourt P, Swanson J, Jaulmes B, Carpentier A, Samama M. Haemostasis; 1986 Apr 12; 16(2):139-46. PubMed ID: 3710291 [Abstract] [Full Text] [Related]
7. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative. Kuziej J, Litinas E, Hoppensteadt DA, Liu D, Walenga JM, Fareed J, Jeske W. Clin Appl Thromb Hemost; 2010 Aug 12; 16(4):377-86. PubMed ID: 20460347 [Abstract] [Full Text] [Related]
8. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate. Maddineni J, Hoppensteadt DA, Cornelli U, Manoni M, Fareed J. Clin Appl Thromb Hemost; 2007 Jan 12; 13(1):52-64. PubMed ID: 17164496 [Abstract] [Full Text] [Related]
10. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride. Andrassy K. Blood Coagul Fibrinolysis; 1993 Dec 12; 4 Suppl 1():S39-43. PubMed ID: 8180328 [Abstract] [Full Text] [Related]
11. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M. Arch Intern Med; 1994 Jan 10; 154(1):49-56. PubMed ID: 8267489 [Abstract] [Full Text] [Related]
12. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins. Harenberg J, Siegele M, Dempfle CE, Stehle G, Heene DL. Thromb Haemost; 1993 Dec 20; 70(6):942-5. PubMed ID: 8165616 [Abstract] [Full Text] [Related]
13. Neutralisation of heparan sulphate and low molecular weight heparin by protamine. Hubbard AR, Jennings CA. Thromb Haemost; 1985 Feb 18; 53(1):86-9. PubMed ID: 3158095 [Abstract] [Full Text] [Related]
14. Biochemical and pharmacologic profile of low molecular weight heparin (LU 47311, Clivarin). Jeske W, Lojewski B, Walenga JM, Hoppensteadt D, Ahsan A, Fareed J. Semin Thromb Hemost; 1993 Feb 18; 19 Suppl 1():229-40. PubMed ID: 8395727 [Abstract] [Full Text] [Related]